ARTICLE | Company News
Qbiogene to develop Glaxo's adenovirus technology
August 9, 2000 7:00 AM UTC
Qbiogene (Montreal, Quebec), which manufactures research tools as well as nucleic acids and proteins for research use, obtained a license to the Admid System, a technology developed by Glaxo Wellcome ...